CHEBI:2950 - azelastine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name azelastine
ChEBI ID CHEBI:2950
Definition A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C22H24ClN3O
Net Charge 0
Average Mass 381.89800
Monoisotopic Mass 381.161
InChI InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3
InChIKey MBUVEWMHONZEQD-UHFFFAOYSA-N
SMILES CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
A lipoxygenase inhibitor that interferes with the action of arachidonate 5-lipoxygenase (EC 1.13.11.34).
H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
Application(s): H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
anti-allergic agent
A drug used to treat allergic reactions.
anti-asthmatic drug
A drug used to treat asthma.
bronchodilator agent
An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing azelastine (CHEBI:2950) has role anti-allergic agent (CHEBI:50857)
azelastine (CHEBI:2950) has role anti-asthmatic drug (CHEBI:49167)
azelastine (CHEBI:2950) has role bronchodilator agent (CHEBI:35523)
azelastine (CHEBI:2950) has role EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor (CHEBI:64964)
azelastine (CHEBI:2950) has role H1-receptor antagonist (CHEBI:37955)
azelastine (CHEBI:2950) has role platelet aggregation inhibitor (CHEBI:50427)
azelastine (CHEBI:2950) is a monochlorobenzenes (CHEBI:83403)
azelastine (CHEBI:2950) is a phthalazines (CHEBI:38768)
azelastine (CHEBI:2950) is a tertiary amino compound (CHEBI:50996)
Incoming azelastine hydrochloride (CHEBI:2951) has part azelastine (CHEBI:2950)
(R)-azelastine (CHEBI:55362) is a azelastine (CHEBI:2950)
(S)-azelastine (CHEBI:55363) is a azelastine (CHEBI:2950)
IUPAC Name
4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one
INNs Sources
azelastina DrugBank
azélastine WHO MedNet
azelastine KEGG DRUG
azelastinum DrugBank
Synonym Source
4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone ChemIDplus
Manual Xrefs Databases
271 DrugCentral
Azelastine Wikipedia
BE778269 Patent
C07768 KEGG COMPOUND
D07483 KEGG DRUG
DB00972 DrugBank
LSM-5127 LINCS
US3813384 Patent
View more database links
Registry Numbers Types Sources
58581-89-8 CAS Registry Number KEGG DRUG
58581-89-8 CAS Registry Number DrugBank
58581-89-8 CAS Registry Number ChemIDplus
900747 Beilstein Registry Number Beilstein
900747 Reaxys Registry Number Reaxys
Citation Waiting for Citations Type Source
22339679 PubMed citation Europe PMC
Last Modified
22 February 2017